Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
G42
Abu Dhabi, Abu Dhabi, United Arab Emiratesg42healthcare.ai ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
G42 (now M42 in healthcare) commercializes large-scale genomic, diagnostic, and AI-driven healthcare and research solutions. Has led major clinical initiatives, such as 4Humanity COVID-19 vaccine trials (>43,000 subjects), launched Emirati Genome Program, and operates the region’s largest Omics facility in Abu Dhabi. Recently partnered with Oracle and Cleveland Clinic to launch a global AI-powered healthcare delivery platform; entered deals for pharmaceutical manufacturing with AstraZeneca; and delivers precision medicine and digital health across MENA region and globally.
- Therapeutic areas
- OncologyInfectious DiseasesOther
- Modalities
- DiagnosticsDigital health platformAI-based solutionsGenome sequencingVaccineSmall molecule
- Industry
- Molecular Diagnostics
02
Partnerships
Beyond the preview
Go deeper on G42.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on G42.